388 related articles for article (PubMed ID: 16049031)
1. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
2. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations.
Wang C; Tan JM; Ho MW; Zaiden N; Wong SH; Chew CL; Eng PW; Lim TM; Dawson TM; Lim KL
J Neurochem; 2005 Apr; 93(2):422-31. PubMed ID: 15816865
[TBL] [Abstract][Full Text] [Related]
4. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
Im E; Yoo L; Hyun M; Shin WH; Chung KC
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
6. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
7. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
[TBL] [Abstract][Full Text] [Related]
8. A disease state mutation unfolds the parkin ubiquitin-like domain.
Safadi SS; Shaw GS
Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
[TBL] [Abstract][Full Text] [Related]
9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
10. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
[TBL] [Abstract][Full Text] [Related]
11. Parkin: much more than a simple ubiquitin ligase.
Alves da Costa C; Checler F
Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
[TBL] [Abstract][Full Text] [Related]
12. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.
Xiong H; Wang D; Chen L; Choo YS; Ma H; Tang C; Xia K; Jiang W; Ronai Z; Zhuang X; Zhang Z
J Clin Invest; 2009 Mar; 119(3):650-60. PubMed ID: 19229105
[TBL] [Abstract][Full Text] [Related]
13. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
[TBL] [Abstract][Full Text] [Related]
14. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
15. The M458L missense mutation disrupts the catalytic properties of Parkin.
Do YJ; Yun SY; Park MY; Kim E
FEBS Lett; 2018 Jan; 592(1):78-88. PubMed ID: 29223129
[TBL] [Abstract][Full Text] [Related]
16. Parkin-associated Parkinson's disease.
von Coelln R; Dawson VL; Dawson TM
Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
[TBL] [Abstract][Full Text] [Related]
17. How do Parkin mutations result in neurodegeneration?
Imai Y; Takahashi R
Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
[TBL] [Abstract][Full Text] [Related]
20. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
